SAT-432 Pharmacokinetics (PK) and Exposure-Response Relationship of Teprotumumab, an Insulin-Like Growth Factor-1 Receptor (IGF-1R) Blocking Antibody, in Active Thyroid Eye Disease (TED)
SAT-432 药代动力学 (PK) 和 Teprotumumab（一种胰岛素样生长因子-1 受体 (IGF-1R) 阻断抗体）在活动性甲状腺眼病 (TED) 中的暴露-反应关系
期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1097/MS9.0000000000001620
Ahmed, Usaid; Saleem, Muhammad Meeran; Osman, Mohamed Ashraf; Shamat, Shamat Fathi; Xin, Yan; Xu, Fengyan; Gao, Yuying; Bhatt, Nivedita; Chamberlain, Jason; Kovalenko, Maria; Sile, Saba; Sun, Rui; Holt, Robert; Ramanathan, Srini
